111 related articles for article (PubMed ID: 25347722)
1. Reduced astrocyte viability at physiological temperatures from magnetically activated iron oxide nanoparticles.
Schaub NJ; Rende D; Yuan Y; Gilbert RJ; Borca-Tasciuc DA
Chem Res Toxicol; 2014 Dec; 27(12):2023-35. PubMed ID: 25347722
[TBL] [Abstract][Full Text] [Related]
2. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of Schwann cell migration across the astrocyte boundary by polysialyltransferase-loaded superparamagnetic nanoparticles under magnetic field.
Xia B; Huang L; Zhu L; Liu Z; Ma T; Zhu S; Huang J; Luo Z
Int J Nanomedicine; 2016; 11():6727-6741. PubMed ID: 28003748
[TBL] [Abstract][Full Text] [Related]
5. Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells.
Marcos-Campos I; Asín L; Torres TE; Marquina C; Tres A; Ibarra MR; Goya GF
Nanotechnology; 2011 May; 22(20):205101. PubMed ID: 21444956
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of iron oxide nanoparticles by cultured brain astrocytes.
Geppert M; Hohnholt M; Gaetjen L; Grunwald I; Bäumer M; Dringen R
J Biomed Nanotechnol; 2009 Jun; 5(3):285-93. PubMed ID: 20055010
[TBL] [Abstract][Full Text] [Related]
7. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes.
Geppert M; Hohnholt MC; Thiel K; Nürnberger S; Grunwald I; Rezwan K; Dringen R
Nanotechnology; 2011 Apr; 22(14):145101. PubMed ID: 21346306
[TBL] [Abstract][Full Text] [Related]
8. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
9. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
Shevtsov M; Multhoff G
Curr Drug Metab; 2016; 17(8):737-744. PubMed ID: 27280470
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-D-Glucose Modified Magnetic Nanoparticles with Dual Functional Properties: Nanothermotherapy and Magnetic Resonance Imaging.
Zhao L; Zheng Y; Yan H; Xie W; Sun X; Li N; Tang J
J Nanosci Nanotechnol; 2016 Mar; 16(3):2401-7. PubMed ID: 27455648
[TBL] [Abstract][Full Text] [Related]
11. Contribution of a 300 kHz alternating magnetic field on magnetic hyperthermia treatment of HepG2 cells.
Wang X; Chen Y; Huang C; Wang X; Zhao L; Zhang X; Tang J
Bioelectromagnetics; 2013 Feb; 34(2):95-103. PubMed ID: 23059525
[TBL] [Abstract][Full Text] [Related]
12. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci.
Subbiahdoss G; Sharifi S; Grijpma DW; Laurent S; van der Mei HC; Mahmoudi M; Busscher HJ
Acta Biomater; 2012 Jul; 8(6):2047-55. PubMed ID: 22406508
[TBL] [Abstract][Full Text] [Related]
13. (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells.
Shi Z; Neoh KG; Kang ET; Shuter B; Wang SC; Poh C; Wang W
ACS Appl Mater Interfaces; 2009 Feb; 1(2):328-35. PubMed ID: 20353220
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Pseudomonas aeruginosa PA01 biofilms by hyperthermia using superparamagnetic nanoparticles.
Park H; Park HJ; Kim JA; Lee SH; Kim JH; Yoon J; Park TH
J Microbiol Methods; 2011 Jan; 84(1):41-5. PubMed ID: 20971135
[TBL] [Abstract][Full Text] [Related]
15. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.
Ivkov R; DeNardo SJ; Daum W; Foreman AR; Goldstein RC; Nemkov VS; DeNardo GL
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7093s-7103s. PubMed ID: 16203808
[TBL] [Abstract][Full Text] [Related]
16. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
17. Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release.
Tai LA; Tsai PJ; Wang YC; Wang YJ; Lo LW; Yang CS
Nanotechnology; 2009 Apr; 20(13):135101. PubMed ID: 19420485
[TBL] [Abstract][Full Text] [Related]
18. [A method of showing thermal effect of iron oxide nanoparticles in alternating magnetic field].
Liu X; Xu B; Xia QS; Zhao TD; Tang JT
Ai Zheng; 2005 Sep; 24(9):1148-50. PubMed ID: 16159444
[TBL] [Abstract][Full Text] [Related]
19. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
Steitz B; Salaklang J; Finka A; O'Neil C; Hofmann H; Petri-Fink A
Bioconjug Chem; 2007; 18(5):1684-90. PubMed ID: 17718533
[TBL] [Abstract][Full Text] [Related]
20. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
